中集安瑞科(03899.HK) 採納股份獎勵計劃 初步預算1.6億元
中集安瑞科(03899.HK)公布,已決議採納2020年股份獎勵計劃,根據計劃可供購買或發行之股份總數累計不得超過公司於採納日期已發行股份總數之2%。根據計劃可向一名參與者以單次或累計授出之股份最高數目不得超過公司於採納日期已發行股份總數之0.5%。
受託人須應用有關金額於聯交所以現行市價按買賣單位購買股份,1.6億元初步已預算用作於聯交所購買股份。倘將授出之股份為由公司將予配發及發行之新股份,公司須促使將有關股份配發及發行予受託人。(el/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.